Literature DB >> 23263830

Increased expression of forkhead box M1 protein is associated with poor prognosis in clear cell renal cell carcinoma.

Xiao-Rong Wu1, Yong-Hui Chen, Dong-Ming Liu, Jian-Jun Sha, Han-Qing Xuan, Juan-Jie Bo, Yi-Ran Huang.   

Abstract

Forkhead box protein M1 (FoxM1) is crucial in the regulation of various biological processes, including cell proliferation, organogenesis, and angiogenesis. Overexpression of FoxM1 is associated with carcinogenesis. In this study, immunohistochemistry was carried out to examine FoxM1 expression in clear cell renal cell carcinoma (ccRCC), and these data were examined for correlation with clinicopathological parameters and prognosis. FoxM1 protein had high expression in 37 of 87 cases of ccRCC (42.5 %), which was significantly higher than in normal tissues, and FoxM1 overexpression was significantly associated with tumor stage (P = 0.005) and recurrence (P = 0.027). The Kaplan-Meier survival analysis demonstrated that FoxM1 expression was significantly associated with shorter recurrence-free survival and overall survival (P = 0.007 and P = 0.008, respectively). Multivariate analysis further demonstrated that FoxM1 was an independent prognostic factor for patients with ccRCC. So FoxM1 might be a potential molecular marker to predict the prognosis of patients with ccRCC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23263830     DOI: 10.1007/s12032-012-0346-1

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  28 in total

1.  FoxM1 is required for execution of the mitotic programme and chromosome stability.

Authors:  Jamila Laoukili; Matthijs R H Kooistra; Alexandra Brás; Jos Kauw; Ron M Kerkhoven; Ashby Morrison; Hans Clevers; René H Medema
Journal:  Nat Cell Biol       Date:  2005-01-16       Impact factor: 28.824

2.  Identification and validation of commonly overexpressed genes in solid tumors by comparison of microarray data.

Authors:  Christian Pilarsky; Michael Wenzig; Thomas Specht; Hans Detlev Saeger; Robert Grützmann
Journal:  Neoplasia       Date:  2004 Nov-Dec       Impact factor: 5.715

3.  The Forkhead box M1 protein regulates the transcription of the estrogen receptor alpha in breast cancer cells.

Authors:  Patricia A Madureira; Rana Varshochi; Demetra Constantinidou; Richard E Francis; R Charles Coombes; Kwok-Ming Yao; Eric W-F Lam
Journal:  J Biol Chem       Date:  2006-06-28       Impact factor: 5.157

4.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

5.  Down-regulation of Notch-1 is associated with Akt and FoxM1 in inducing cell growth inhibition and apoptosis in prostate cancer cells.

Authors:  Zhiwei Wang; Yiwei Li; Aamir Ahmad; Sanjeev Banerjee; Asfar S Azmi; Dejuan Kong; Christine Wojewoda; Lucio Miele; Fazlul H Sarkar
Journal:  J Cell Biochem       Date:  2011-01       Impact factor: 4.429

6.  Critical role and regulation of transcription factor FoxM1 in human gastric cancer angiogenesis and progression.

Authors:  Qiang Li; Nu Zhang; Zhiliang Jia; Xiangdong Le; Bingbing Dai; Daoyan Wei; Suyun Huang; Dongfeng Tan; Keping Xie
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

7.  The Forkhead Box m1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer.

Authors:  Il-Man Kim; Timothy Ackerson; Sneha Ramakrishna; Maria Tretiakova; I-Ching Wang; Tanya V Kalin; Michael L Major; Galina A Gusarova; Helena M Yoder; Robert H Costa; Vladimir V Kalinichenko
Journal:  Cancer Res       Date:  2006-02-15       Impact factor: 12.701

8.  Over-expression of FOXM1 transcription factor is associated with cervical cancer progression and pathogenesis.

Authors:  D W Chan; S Y M Yu; P M Chiu; K M Yao; V W S Liu; A N Y Cheung; H Y S Ngan
Journal:  J Pathol       Date:  2008-07       Impact factor: 7.996

Review 9.  Diagnostic and prognostic molecular markers for renal cell carcinoma: a critical appraisal of the current state of research and clinical applicability.

Authors:  Christian Eichelberg; Kerstin Junker; Börje Ljungberg; Holger Moch
Journal:  Eur Urol       Date:  2009-01-13       Impact factor: 20.096

10.  Prognostic significance of morphologic parameters in renal cell carcinoma.

Authors:  S A Fuhrman; L C Lasky; C Limas
Journal:  Am J Surg Pathol       Date:  1982-10       Impact factor: 6.394

View more
  14 in total

1.  Increased expression of forkhead box M1 is associated with aggressive phenotype and poor prognosis in estrogen receptor-positive breast cancer.

Authors:  Hyein Ahn; Jongmin Sim; Rehman Abdul; Min Sung Chung; Seung Sam Paik; Young-Ha Oh; Chan Kum Park; Kiseok Jang
Journal:  J Korean Med Sci       Date:  2015-03-19       Impact factor: 2.153

Review 2.  Prognostic Value of FOXM1 in Patients with Malignant Solid Tumor: A Meta-Analysis and System Review.

Authors:  Jun Dai; Lili Yang; Jinyu Wang; Ying Xiao; Qiurong Ruan
Journal:  Dis Markers       Date:  2015-07-22       Impact factor: 3.434

3.  FoxM1 overexpression promotes cell proliferation and migration and inhibits apoptosis in hypopharyngeal squamous cell carcinoma resulting in poor clinical prognosis.

Authors:  Yan Chen; Yifei Liu; Haosheng Ni; Chuanjin Ding; Xiaobo Zhang; Zhenxin Zhang
Journal:  Int J Oncol       Date:  2017-08-09       Impact factor: 5.650

Review 4.  Prognostic value of FOXM1 in solid tumors: a systematic review and meta-analysis.

Authors:  Lijun Li; Dang Wu; Qun Yu; Lingdi Li; Pin Wu
Journal:  Oncotarget       Date:  2017-05-09

5.  LINC01094 triggers radio-resistance in clear cell renal cell carcinoma via miR-577/CHEK2/FOXM1 axis.

Authors:  Yufeng Jiang; Wei Li; Yang Yan; Xudong Yao; Wenyu Gu; Haimin Zhang
Journal:  Cancer Cell Int       Date:  2020-06-24       Impact factor: 5.722

6.  Integrated epigenomic profiling reveals endogenous retrovirus reactivation in renal cell carcinoma.

Authors:  Kyle T Siebenthall; Chris P Miller; Jeff D Vierstra; Julie Mathieu; Maria Tretiakova; Alex Reynolds; Richard Sandstrom; Eric Rynes; Eric Haugen; Audra Johnson; Jemma Nelson; Daniel Bates; Morgan Diegel; Douglass Dunn; Mark Frerker; Michael Buckley; Rajinder Kaul; Ying Zheng; Jonathan Himmelfarb; Hannele Ruohola-Baker; Shreeram Akilesh
Journal:  EBioMedicine       Date:  2019-03-01       Impact factor: 8.143

7.  SUMOylation of FOXM1B alters its transcriptional activity on regulation of MiR-200 family and JNK1 in MCF7 human breast cancer cells.

Authors:  Chiung-Min Wang; Runhua Liu; Lizhong Wang; Leticia Nascimento; Victoria C Brennan; Wei-Hsiung Yang
Journal:  Int J Mol Sci       Date:  2014-06-10       Impact factor: 5.923

8.  FoxM1 is associated with metastasis in colorectal cancer through induction of the epithelial-mesenchymal transition.

Authors:  Bao-Ying Fei; Xujun He; Jie Ma; Mei Zhang; Rui Chai
Journal:  Oncol Lett       Date:  2017-09-21       Impact factor: 2.967

9.  Dual Strands of Pre-miR-149 Inhibit Cancer Cell Migration and Invasion through Targeting FOXM1 in Renal Cell Carcinoma.

Authors:  Atsushi Okato; Takayuki Arai; Yasutaka Yamada; Sho Sugawara; Keiichi Koshizuka; Lisa Fujimura; Akira Kurozumi; Mayuko Kato; Satoko Kojima; Yukio Naya; Tomohiko Ichikawa; Naohiko Seki
Journal:  Int J Mol Sci       Date:  2017-09-13       Impact factor: 5.923

10.  Dysregulation of miR-6868-5p/FOXM1 circuit contributes to colorectal cancer angiogenesis.

Authors:  Ye Wang; Meijuan Wu; Zengjie Lei; Mengxi Huang; Zhiping Li; Liya Wang; Qijun Cao; Dong Han; Yue Chang; Yanyan Chen; Xiaobei Liu; Lijun Xue; Xiaobei Mao; Jian Geng; Yanan Chen; Tingting Dai; Lili Ren; Qian Wang; Hongju Yu; Cheng Chen; Xiaoyuan Chu
Journal:  J Exp Clin Cancer Res       Date:  2018-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.